Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group. Ascione A, et al. Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28. Infection. 2018. PMID: 29808463
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
Petta S, Marzioni M, Russo P, Aghemo A, Alberti A, Ascione A, Antinori A, Bruno R, Bruno S, Chirianni A, Gaeta GB, Giannini EG, Merli M, Messina V, Montilla S, Perno CF, Puoti M, Raimondo G, Rendina M, Silberstein FC, Villa E, Zignego AL, Pani L, Craxì A; ABACUS study group; AIFA team. Petta S, et al. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):427-434. doi: 10.1016/S2468-1253(17)30048-1. Epub 2017 Apr 10. Lancet Gastroenterol Hepatol. 2017. PMID: 28497758
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Mocroft A, et al. Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17. Lancet HIV. 2016. PMID: 26762990 Clinical Trial.
Does HIV infection favor the sexual transmission of hepatitis C?
Filippini P, Coppola N, Scolastico C, Rossi G, Onofrio M, Sagnelli E, Piccinino F. Filippini P, et al. Among authors: onofrio m. Sex Transm Dis. 2001 Dec;28(12):725-9. doi: 10.1097/00007435-200112000-00010. Sex Transm Dis. 2001. PMID: 11725228
Hepatitis viruses and HIV infection in the Naples area.
Filippini P, Coppola N, Scolastico C, Rossi G, Battaglia M, Onofrio M, Pisapia R, Marrocco C, Sagnelli C, Piccinino F, Sagnelli E. Filippini P, et al. Among authors: onofrio m. Infez Med. 2003 Sep;11(3):139-45. Infez Med. 2003. PMID: 14985646 Free article.
Antibodies to hepatitis A virus in Italian patients with chronic liver disease.
Sagnelli E, Rossi G, Coppola N, Scolastico C, Onofrio M, Filippini P, Chiaramonte M, Pizzigall E, Aceti A, Spadaro A, Raimondo G, Piccinino F. Sagnelli E, et al. Among authors: onofrio m. Epidemiol Infect. 2001 Oct;127(2):341-6. doi: 10.1017/s0950268801005854. Epidemiol Infect. 2001. PMID: 11693512 Free PMC article.
Helicobacter spp. and liver diseases.
Coppola N, De Stefano G, Marrocco C, Scarano F, Scolastico C, Tarantino L, Rossi G, Battaglia M, Onofrio M, D'Aniello F, Pisapia R, Sagnelli C, Sagnelli E, Piccinino F, Giorgio A, Filippini P. Coppola N, et al. Among authors: onofrio m. Infez Med. 2003 Dec;11(4):201-7. Infez Med. 2003. PMID: 14988668 Free article.
989 results